Venture Capital
Insights into Canadian venture capital: Tracking investment trends, market cycles, and their impact on small caps.
How Albemarle Became the World’s Dominant Lithium Player
The history of Albemarle and its rise to the top of the lithium sector along with its plan to process lithium from recycled batteries.
Back in Triple Digits
The equity markets performed well beyond expectation this July, with two of the contest's top performing stocks generating triple digits returns this month.
Volatility Remains but Multiple Sectors Reporting Impressive Gains
The Stock Challenge Index saw significant volatility in the first week of July, but has been on a downward spiral ever since.
Crypto’s Delicate Universe
The perceived crypto promise of transforming payments and the overall financial system is resonating with investors on a large-scale...but will it hold?
Lithium’s Production Problem
Lithium is arguably the hottest commodity today, and although investment in new sources has lagged in the past, that is now changing.
Join
75,000+
Independent
Investors
Entheon Biomedical Subsidiary, HaluGen Life Sciences, Announces Agreement with Third
Entheon Biomedical Corp. a biotechnology company focused on developing psychedelic medicines to treat addiction, has announced an agreement with 3W Wellness Inc. ("Third Wave'')
Rritual Superfoods Lists with Health Food Marketplace ‘The Good Trends’
Rritual Superfoods Inc. is excited to announce the listing of the Rritual Superfoods product line on leading health food marketplace, 'The Good Trends.'
Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness
Entheon Biomedical Corp., and Silo Wellness Inc. have signed a referral agreement to help drive brand awareness of the Psychedelics Genetic Test kit...
Rritual Superfoods Advances Toward Full Rollout with CROSSMARK
Rritual Superfoods Inc. is excited to announce the Company has conducted and completed multiple training sessions with CROSSMARK Account and Business Executives.
Rritual Superfoods to Present at the Lytham Partners Summer 2021
Rritual Superfoods Inc. is pleased to announce that it will present at the Lytham Partners Summer 2021 Investor Conference on Monday, June 14, 2021 at 9:30am ET.
Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences, Psychedelics Genetic Test
Entheon Biomedical Corp., a biotechnology company focused on developing psychedelic medicines to treat addiction, announced its Psychedelics Genetic Test Kit, developed by its wholly-owned subsidiary, HaluGen Life Sciences Inc. ("HaluGen"), is now available for sale in the United States.
Rritual Superfoods Announces ECRM European Virtual Conference Attendance
Rritual Superfoods Inc. is pleased to announce that the Company has scheduled several meetings with international retailers at the ECRM European Vitamins, Minerals, Herbals, Supplements Program.
Rritual Superfoods Surpasses Full Year 2021 USA Retail Distribution Targets
Rritual Superfoods Inc. is excited to announce that the Company has surpassed its retail distribution targets for the end of 2021, exceeding 2400 retail locations and 10,000 points of distribution within the first half of the year.
Mason Graphite Announces Successful Completion of Cycle Testing and Transition
Mason Graphite Inc. is very pleased to announce that the cycling tests, carried out on its full prototype pouch cell batteries, are conclusive, having crossed the objective of 1,000 charge & discharge cycles while maintaining a capacity retention of 80.6%.
Rritual Superfoods Now Available Online at Rite Aid
Rritual Superfoods Inc. is excited to announce the Company's premium brand of functional superfoods have launched online with Rite Aid.
Rritual and NEXE Sign Letter of Intent to Pursue Strategic
Rritual Superfoods Inc. is excited to announce that the Company has signed a non-binding Letter of Intent with NEXE Technologies Corp. with the intent to form a strategic alliance leveraging the combined strengths of each Company
Entheon Biomedical Announces DMT Drug Supply Agreement with Ofichem Group
Entheon Biomedical Corp., a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it has entered into a drug-supply agreement with Laboratorium Ofichem BV.
Join 75,000+ Independent Investors
Get sharp, weekly insight on capital flows, commodity cycles, and macro trends shaping tomorrow’s markets.
